Glaxosmithkline Pharmaceuticals Ltd.
GLAXO Share PricePharmaceuticals & Drugs
₹2,819.1
48.8 (1.8%)
As on September 8, 2025
Exchange Scrips: BSE500660NSEGLAXOISININE159A01016
Market Cap ₹ 47,471 Cr
P/E Ratio 51.49
Dividend Yield 0.19 %
Performance
Market performance
Open2,821
High2,835
Volumes69,313
Prev2,819.1
Low2,758.1
As on2025-09-08
Historical performance
1 Year High3,515.7
3 Year High3,515.7
5 Year High3,515.7
1 Year Low1,921
3 Year Low1,227
5 Year Low1,227
Fundamentals
Company Valuation
Market Cap (₹Cr)
47,471
Face Value (₹)
10
P/E Ratio
51.49
Dividend Yield
0.19 %
Investment Returns
1 Year
-0.4%
3 Years
96%
5 Years
72.4%
10 Years
69.7%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 2,794.06 | Bullish |
| 10-DMA | 2,790.45 | Bullish |
| 20-DMA | 2,766.76 | Bullish |
| 50-DMA | 2,998.17 | Bearish |
| 100-DMA | 3,032.18 | Bearish |
| 200-DMA | 2,710.3 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | 4 | 4 | 4 | 4 | 4 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 123625 | 121881 | 119621 | 119224 | 118511 |
| Government | 2 | 3 | 3 | 2 | 2 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 51.49.
- 3Y Stock Price CAGR of the stock is 25.4.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹13233 Million.
- The company generated revenue of ₹37492 Million in the previous financial year.
Glaxosmithkline Pharmaceuticals Ltd.
2819.148.8 (1.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 988031.2
No. of Shares: 350 (Approx)
Performance:-1.2%
P/L: ₹-11968.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent